HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AbbVie Inc. (ABBV) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed
April 08, 2022 18:01 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, April 08, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges AbbVie Inc. (NYSE: ABBV) investors who suffered significant losses to submit your losses now. A securities fraud class action...
Hagens Berman Reminds Investors in AbbVie Inc. (NYSE: ABBV) of the Firm’s Ongoing Investigation and the November 20, 2018 Securities Class Action Lead Plaintiff Deadline
October 18, 2018 16:01 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in AbbVie Inc. (NYSE: ABBV) of the November 20, 2018 Lead Plaintiff deadline in the pending...
Hagens Berman Alerts Investors in AbbVie Inc. (NYSE: ABBV) to the November 20, 2018 Securities Class Action Lead Plaintiff Deadline
September 24, 2018 16:33 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in AbbVie Inc. (NYSE: ABBV) to the November 20, 2018 Lead Plaintiff deadline in the securities...